None listed
Conditions
Brief summary
Before service provision models for the management of the complex array of disorders of movement, cognition and autonomic function associated with Parkinson can be comprehensively evaluated, there is a need for preliminary investigations to determine the best measurement tools to quantify therapy outcomes and program costs. Further data are also needed to map disease progression in a sample of people with Parksinon, providing a frame of reference against which inter-disciplinary therapy outcomes can later be evaluated. This study aims to address these needs as the first step in measuring the outcomes and costs of an inter-professional team model for the comprehensive management of people with Parkinson.
Interventions
Parkinson's disease is a chronic and progressive neurological condition affecting the basil ganglia deep within the brain leading to a reduction in the size and speed of sequential movements. The disease results in significant cost to the health care system including medication and medical and allied health services. This
prospective cohort study will evaluate primary and secondary clinical, health related quality of life and cost data over a 12 month period for people with Parkinson.
Sponsors
Southern Health
Eligibility
Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No
Inclusion criteria
A confirmed diagnosis of idiopathic Parkinson, informed consent (including to access Medicare Australia claims data), carer participation in case of cognitive impairment (Mini-Mental State Examination (MMSE<24/30)), and ability to attend assessment clinics and to complete questionnaires over a 12-month period.
Exclusion criteria
Hoehn & Yahr Stage V, non-ambulatory, or have co-existing neurological conditions which are related to significant motor and cognitive function impairment, are unwilling to provide informed consent, or to participate in a clinical trial.
Outcome results
None listed